Synapsin Ia/b activators belong to a unique class of chemical compounds that specifically target the synapsin Ia/b proteins. These proteins, part of the larger synapsin family, are phosphoproteins that play crucial roles in the modulation and regulation of neurotransmitter release in neurons. Found predominantly in the synaptic vesicles, they associate with the vesicle membranes and are known to influence neurotransmitter storage, release, and synaptic plasticity. The presence of synapsin Ia/b can be seen throughout various regions of the brain, and they are key components in the complex machinery that facilitates synaptic transmission.
The chemical class of synapsin Ia/b activators aims to enhance or modulate the activity of these proteins. Their mechanism of action often revolves around the modulation of the phosphorylation state of synapsin Ia/b. Phosphorylation, a post-translational modification, is essential for the functioning of synapsin Ia/b. When phosphorylated, synapsin tends to detach from the synaptic vesicles, which can then move towards the active zone of the synapse and participate in neurotransmitter release. On the other hand, when dephosphorylated, they help anchor the vesicles away from the active zone, preventing their release. Activators of synapsin Ia/b influence this delicate balance, often promoting a state that favors neurotransmission. Their chemical structures can vary, but they are generally designed to interact with synapsin Ia/b either directly or indirectly, modifying its activity and influencing synaptic functions. The exploration and understanding of these activators are ongoing, offering deeper insights into the intricate world of synaptic physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
This compound is often used to raise cyclic AMP levels in many types of cells and tissues, thus potentially leading to an activation of PKA, which can phosphorylate synapsins. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
An inhibitor of phosphodiesterase 4, it elevates cAMP levels, which could lead to PKA-mediated phosphorylation of synapsins. | ||||||
Aniracetam | 72432-10-1 | sc-203514 sc-203514A | 50 mg 250 mg | $115.00 $456.00 | ||
A nootropic that may enhance synaptic release, possibly via effects on synapsin, although the direct mechanism is still under investigation. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $120.00 $486.00 | 1 | |
An anticonvulsant that might influence synapsin I phosphorylation, though the exact mechanism and specificity remain to be fully clarified. | ||||||